Welcome to AdaptiM3D
AdaptiM3D is reducing pharmaceutical clinical trial times and costs using an innovative 3D printing technology.
As a spin-out from the University of Strathclyde, we're focused on transforming how clinical trials are conducted, working to deliver benefits for biotechs, trial sites and medics, by enabling new medicines to reach patients faster.
Cost and time savings in clinical supply
-
Saving 2-3 months on the critical path for clinical trial supply by replacing multiple processes with one operation
-
Reducing manufacturing costs for clinical trial supply by 30-50% - by simplifying the manufacturing process
-
Enabling rapid re-supply after a dose change, reducing total clinical trial elapsed times by eliminating by 2-3 months
Advanced 3D printing technology
AdaptiM3D utilises an advanced 3D printing technology specifically designed for pharmaceutical applications. Our system allows for precise dosing and rapid formulation adjustments without the need for traditional multi-step manufacturing.
Our Supporters
